Home Mf Research Baroda Bnp Paribas Health And Wellness Fund

Baroda Bnp Paribas Health And Wellness Fund

-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • SI
Fund info
NAV (as on 2026-08-21)
₹10.67 -0.25%
AUM (Fund Size)
553.17 Cr
Expense Ratio
N/A
Exit load
Exit load of 1,000.00% if redeemed within 365 days.
Risk
Very high
AMC
Baroda BNP Paribas Mutual Fund
View AMC Details

SIP Returns

Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2026-08-14 ₹1,000.00 ₹997.92
-0.21 %
Two Week 2026-08-06 ₹1,000.00 ₹994.15
-0.59 %
One Month 2026-07-22 ₹1,000.00 ₹1,011.75
1.18 %
Three Months 2026-05-25 ₹3,000.00 ₹3,131.79
4.39 %
Six Months 2026-02-23 ₹6,000.00 ₹6,552.35
9.21 %
One Year 2025-08-21 ₹12,000.00 ₹13,247.40
10.39 %
Since Inception 2025-06-27 ₹15,000.00 ₹16,398.43
9.32 %

Return Calculator

SIP Amount
1M
6M
1Y
3Y
5Y
Investment
₹0
Maturity Value
₹0
Abs. Returns
0
Current CAGR
0

Portfolio

Allocation of Equity and Debt Asset Classes.

Equity N/A
Debt N/A
Others N/A

Sectors Holding in Baroda Bnp Paribas Health And Wellness Fund

Pharmaceuticals & Biotechnology
72.66%
Healthcare Services
17.24%
Insurance
5.44%
Other
1.97%
IT - Services
1.52%
Retailing
1.17%

Companies Holding in Baroda Bnp Paribas Health And Wellness Fund

Sun Pharmaceutical Industries Limited
7.58%
Lupin Limited
6.56%
Laurus Labs Limited
6.31%
IPCA Laboratories Limited
5.80%
Torrent Pharmaceuticals Limited
5.43%
Divi's Laboratories Limited
5.35%
Apollo Hospitals Enterprise Limited
4.87%
JB Chemicals & Pharmaceuticals Limited
4.57%
Fortis Healthcare Limited
4.32%
AstraZeneca Pharma India Limited
3.87%
Emcure Pharmaceuticals Limited
3.60%
SBI Life Insurance Company Limited
3.19%
Glenmark Pharmaceuticals Limited
3.19%
Mankind Pharma Limited
2.99%
Aurobindo Pharma Limited
2.85%
Dr. Lal Path Labs Limited
2.53%
Zydus Lifesciences Limited
2.51%
Aster DM Healthcare Limited
2.41%
Acutaas Chemicals Limited
2.30%
Max Financial Services Limited
2.25%
Abbott India Limited
2.07%
Ajanta Pharma Limited
1.95%
Nephrocare Health Services Ltd
1.84%
Concord Biotech Limited
1.74%
Inventurus Knowledge Solutions Limited
1.52%
Metropolis Healthcare Limited
1.27%
Dr. Reddy's Laboratories Limited
1.23%
MedPlus Health Services Limited
1.17%
Gland Pharma Limited
1.13%
Cipla Limited
1.06%
Procter & Gamble Health Limited
0.57%
Clearing Corporation Of India Ltd
2.55%
Net Receivables / (Payables)
-0.58%

Risk Ratios

Std. Deviation N/A
Beta N/A
Sharpe Ratio N/A
Lock In Period N/A
Residual Maturity N/A

Standard Deviation:

Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.

Beta:

Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.

Sharpe Ratio:

The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.

Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.

Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.

Risk-O-Meter

Investors understand that their principal will be at
Very High

Scheme Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.

Scheme Details

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio Regular
N/A
Expense Ratio Direct
N/A
Lock-in Period
N/A
Fund Age
N/A
Benchmark
BSE Healthcare Total Return Index, Nifty 50
Fund managers
Sanjay Chawla
Experience
Rohan Korde
21 Years Experience

Exit Load

Exit load of 1,000.00% if redeemed within 365 days .

FAQs

Is a Mutual Fund with a Lower NAV Better?

What Are the Charges in Mutual Fund Investments?

What Are the Tax Benefits of Mutual Funds?

Is It a Good Time to Invest in Mutual Funds?

What Is the Difference Between Dividend and Growth Plans?

Should I Invest in Infrastructure Funds?

What Are Sector-Specific Funds/Schemes?

What Happens If I Miss an SIP Payment?

How Can I Compare Different Mutual Funds?